Dave Hallett is the founder of Exscientia. Latest round: Growth. Backed by Recursion Pharmaceuticals. Based in Dundee, Scotland.
Dave Hallett is a co-founder of Exscientia, an AI-driven drug design company that originated as a spin-out from the University of Dundee in 2012. He served as the Chief Operating Officer, a role he assumed in 2020. Exscientia was acquired by Recursion Pharmaceuticals in August 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library